These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20194829)

  • 1. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
    Blanco C; Heimberg RG; Schneier FR; Fresco DM; Chen H; Turk CL; Vermes D; Erwin BA; Schmidt AB; Juster HR; Campeas R; Liebowitz MR
    Arch Gen Psychiatry; 2010 Mar; 67(3):286-95. PubMed ID: 20194829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.
    Heimberg RG; Liebowitz MR; Hope DA; Schneier FR; Holt CS; Welkowitz LA; Juster HR; Campeas R; Bruch MA; Cloitre M; Fallon B; Klein DF
    Arch Gen Psychiatry; 1998 Dec; 55(12):1133-41. PubMed ID: 9862558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.
    Liebowitz MR; Heimberg RG; Schneier FR; Hope DA; Davies S; Holt CS; Goetz D; Juster HR; Lin SH; Bruch MA; Marshall RD; Klein DF
    Depress Anxiety; 1999; 10(3):89-98. PubMed ID: 10604081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.
    Liebowitz MR; Schneier F; Campeas R; Hollander E; Hatterer J; Fyer A; Gorman J; Papp L; Davies S; Gully R
    Arch Gen Psychiatry; 1992 Apr; 49(4):290-300. PubMed ID: 1558463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
    Versiani M; Nardi AE; Mundim FD; Alves AB; Liebowitz MR; Amrein R
    Br J Psychiatry; 1992 Sep; 161():353-60. PubMed ID: 1393304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotherapy in the overall management strategy for social anxiety disorder.
    Shear MK; Beidel DC
    J Clin Psychiatry; 1998; 59 Suppl 17():39-46. PubMed ID: 9811429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenelzine efficacy in refractory social anxiety disorder: a case series.
    Aarre TF
    Nord J Psychiatry; 2003; 57(4):313-5. PubMed ID: 12888407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.
    Davidson JR; Foa EB; Huppert JD; Keefe FJ; Franklin ME; Compton JS; Zhao N; Connor KM; Lynch TR; Gadde KM
    Arch Gen Psychiatry; 2004 Oct; 61(10):1005-13. PubMed ID: 15466674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
    Gelernter CS; Uhde TW; Cimbolic P; Arnkoff DB; Vittone BJ; Tancer ME; Bartko JJ
    Arch Gen Psychiatry; 1991 Oct; 48(10):938-45. PubMed ID: 1929764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-behavioral group therapy versus group psychotherapy for social anxiety disorder among college students: a randomized controlled trial.
    Bjornsson AS; Bidwell LC; Brosse AL; Carey G; Hauser M; Mackiewicz Seghete KL; Schulz-Heik RJ; Weatherley D; Erwin BA; Craighead WE
    Depress Anxiety; 2011 Nov; 28(11):1034-42. PubMed ID: 22076970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial.
    Hedman E; Andersson G; Ljótsson B; Andersson E; Rück C; Mörtberg E; Lindefors N
    PLoS One; 2011 Mar; 6(3):e18001. PubMed ID: 21483704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention bias modification augments cognitive-behavioral group therapy for social anxiety disorder: a randomized controlled trial.
    Lazarov A; Marom S; Yahalom N; Pine DS; Hermesh H; Bar-Haim Y
    Psychol Med; 2018 Oct; 48(13):2177-2185. PubMed ID: 29258631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
    Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
    Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
    Prasko J; Dockery C; Horácek J; Houbová P; Kosová J; Klaschka J; Pasková B; Praskova H; Seifertová D; Záleský R; Höschl C
    Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavioral group therapy for social phobia with or without attention training: a controlled trial.
    McEvoy PM; Perini SJ
    J Anxiety Disord; 2009 May; 23(4):519-28. PubMed ID: 19059753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
    Liebowitz MR; Gorman JM; Fyer AJ; Campeas R; Levin AP; Sandberg D; Hollander E; Papp L; Goetz D
    J Clin Psychiatry; 1988 Jul; 49(7):252-7. PubMed ID: 3292516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.